Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Magmas
, a conserved mammalian protein essential for eukaryotic development, is overexpressed in prostate carcinomas and cells exposed to
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
). Reduced
Magmas
expression resulted in decreased proliferative rates in cultured cells. However, the cellular function of
Magmas
is still elusive. In this report, we have showed that human
Magmas
is an ortholog of Saccharomyces cerevisiae Pam16 having similar functions and is critical for protein translocation across mitochondrial inner membrane. Human
Magmas
shows a complete growth complementation of Deltapam16 yeast cells at all temperatures. On the basis of our analysis, we report that
Magmas
localizes into mitochondria and is peripherally associated with inner mitochondrial membrane in yeast and humans.
Magmas
forms a stable subcomplex with J-protein Pam18 or DnaJC19 through its C-terminal region and is tethered to TIM23 complex of yeast and humans. Importantly, amino acid alterations in
Magmas
leads to reduced stability of the subcomplex with Pam18 that results in temperature sensitivity and in vivo protein translocation defects in yeast cells. These observations highlight the central role of
Magmas
in protein import and mitochondria biogenesis. In humans, absence of a functional DnaJC19 leads to dilated cardiac myophathic syndrome (DCM), a genetic disorder with characteristic features of cardiac myophathy and neurodegeneration. We propose that the mutations resulting in decreased stability of functional
Magmas
:DnaJC19 subcomplex at human TIM23 channel leads to impaired protein import and cellular respiration in DCM patients. Together, we propose a model showing how
Magmas
:DnaJC19 subcomplex is associated with TIM23 complex and thus regulates mitochondrial import process.
...
PMID:Role of Magmas in protein transport and human mitochondria biogenesis. 2005 69
Pituitary tumors are mostly benign, being locally invasive in 5-35% of cases. Deregulation of several genes has been suggested as a possible alteration underlying the development and progression of pituitary tumors. We here report the identification of a cDNA, corresponding to
Magmas
gene (mitochondria-associated protein involved in
granulocyte-macrophage colony-stimulating factor
signal transduction), which is highly expressed in two different ACTH-secreting mouse pituitary adenoma cell lines as compared with normal pituitary as well as in two thirds of 64 examined pituitary adenomas as compared with human normal pituitary. Tim 16, the mitochondrial protein encoded by
Magmas
, was indeed expressed in a mouse ACTH-secreting pituitary adenoma cell line, AtT-20 D16v-F2 cells, in a subcellular compartment likely corresponding to mitochondria.
Magmas
silencing determined a reduced rate of DNA synthesis, an accumulation in G1 phase, and a concomitant decrease in S phase in At-T20 D16v-F2 cells. Moreover,
Magmas
-silenced cells displayed basal caspase 3/7 activity and DNA fragmentation levels similar to control cells, which both increased under proapoptotic stimuli. Our data demonstrate that
Magmas
is overexpressed in mouse and human ACTH-secreting pituitary adenomas. Moreover, our results show that
Magmas
protects pituitary cells from apoptosis, suggesting its possible involvement in neoplastic transformation.
...
PMID:Magmas, a gene newly identified as overexpressed in human and mouse ACTH-secreting pituitary adenomas, protects pituitary cells from apoptotic stimuli. 2071 56
Loss of expression of the methylation-controlled J gene, MCJ (DNAJC15), is observed in cases of several tumors and plays a crucial role in the chemoresistance of ovarian cancer cells. Aside from the pathophysiological effects, almost nothing is known about the cellular function of MCJ. Here, we provide the first evidence that MCJ acts in the biogenesis of mitochondria. Our results demonstrate that MCJ is located in mitochondria. It is anchored in the mitochondrial inner membrane with the C-terminal J domain facing the matrix space. We show that MCJ forms a stable subcomplex with a component of the mitochondrial import motor,
MAGMAS
, a protein overexpressed in cells treated with
granulocyte-macrophage colony-stimulating factor
and in prostate carcinomas. In addition, MCJ and
MAGMAS
interact with the core components of the TIM23 pre-protein translocase. We demonstrate that the recombinant soluble MCJ domain stimulates the ATPase activity of the human mtHsp70 chaperone, mortalin, the central component of the import motor of the TIM23 translocase. This stimulation is counteracted by
MAGMAS
. Moreover, pre-protein import into mitochondria is impaired in the absence of MCJ. Interestingly, MCJ is able to take over the function of Tim14, the essential J co-chaperone of the mitochondrial protein import motor in yeast. In summary, our results show that MCJ functions as J co-chaperone of the human TIM23 pre-protein translocase, suggesting a link between mitochondrial pre-protein import and tumorigenesis.
...
PMID:Methylation-controlled J-protein MCJ acts in the import of proteins into human mitochondria. 2326 64